BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30002371)

  • 1. Lineage marker synchrony in hematopoietic genealogies refutes the PU.1/GATA1 toggle switch paradigm.
    Strasser MK; Hoppe PS; Loeffler D; Kokkaliaris KD; Schroeder T; Theis FJ; Marr C
    Nat Commun; 2018 Jul; 9(1):2697. PubMed ID: 30002371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios.
    Hoppe PS; Schwarzfischer M; Loeffler D; Kokkaliaris KD; Hilsenbeck O; Moritz N; Endele M; Filipczyk A; Gambardella A; Ahmed N; Etzrodt M; Coutu DL; Rieger MA; Marr C; Strasser MK; Schauberger B; Burtscher I; Ermakova O; Bürger A; Lickert H; Nerlov C; Theis FJ; Schroeder T
    Nature; 2016 Jul; 535(7611):299-302. PubMed ID: 27411635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gata1/pu.1 lineage fate paradigm varies between blood populations and is modulated by tif1γ.
    Monteiro R; Pouget C; Patient R
    EMBO J; 2011 Mar; 30(6):1093-103. PubMed ID: 21336259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards an understanding of lineage specification in hematopoietic stem cells: a mathematical model for the interaction of transcription factors GATA-1 and PU.1.
    Roeder I; Glauche I
    J Theor Biol; 2006 Aug; 241(4):852-65. PubMed ID: 16510158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells.
    Chang HH; Hemberg M; Barahona M; Ingber DE; Huang S
    Nature; 2008 May; 453(7194):544-7. PubMed ID: 18497826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoid lineage fate decision of hematopoietic stem cells.
    Akashi K
    Ann N Y Acad Sci; 2009 Sep; 1176():18-25. PubMed ID: 19796229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational modeling of the hematopoietic erythroid-myeloid switch reveals insights into cooperativity, priming, and irreversibility.
    Chickarmane V; Enver T; Peterson C
    PLoS Comput Biol; 2009 Jan; 5(1):e1000268. PubMed ID: 19165316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limit-cycle oscillatory coexpression of cross-inhibitory transcription factors: a model mechanism for lineage promiscuity.
    Bokes P; King JR
    Math Med Biol; 2019 Mar; 36(1):113-137. PubMed ID: 30869799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the pathways of early adult hematopoiesis.
    Murre C
    Cell Stem Cell; 2007 Oct; 1(4):357-8. PubMed ID: 18371371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages.
    Arinobu Y; Mizuno S; Chong Y; Shigematsu H; Iino T; Iwasaki H; Graf T; Mayfield R; Chan S; Kastner P; Akashi K
    Cell Stem Cell; 2007 Oct; 1(4):416-27. PubMed ID: 18371378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of PU.1 concentration in hematopoietic lineage commitment and maturation.
    Dahl R; Simon MC
    Blood Cells Mol Dis; 2003; 31(2):229-33. PubMed ID: 12972030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M-CSF instructs myeloid lineage fate in single haematopoietic stem cells.
    Mossadegh-Keller N; Sarrazin S; Kandalla PK; Espinosa L; Stanley ER; Nutt SL; Moore J; Sieweke MH
    Nature; 2013 May; 497(7448):239-43. PubMed ID: 23575636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.
    Nerlov C; Graf T
    Genes Dev; 1998 Aug; 12(15):2403-12. PubMed ID: 9694804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bistable genetic switch which does not require high co-operativity at the promoter: a two-timescale model for the PU.1-GATA-1 interaction.
    Bokes P; King JR; Loose M
    Math Med Biol; 2009 Jun; 26(2):117-32. PubMed ID: 19181622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PU.1 Mimic Synthetic Peptides Selectively Bind with GATA-1 and Allow c-Jun PU.1 Binding to Enhance Myelopoiesis.
    Raghav PK; Gangenahalli G
    Int J Nanomedicine; 2021; 16():3833-3859. PubMed ID: 34113102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding.
    Rogers JH; Owens KS; Kurkewich J; Klopfenstein N; Iyer SR; Simon MC; Dahl R
    Biomed Res Int; 2016; 2016():3983686. PubMed ID: 26942192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The erythroid/myeloid lineage fate paradigm takes a new player.
    Xu J; Orkin SH
    EMBO J; 2011 Mar; 30(6):983-5. PubMed ID: 21407249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.
    Gangenahalli GU; Gupta P; Saluja D; Verma YK; Kishore V; Chandra R; Sharma RK; Ravindranath T
    Stem Cells Dev; 2005 Apr; 14(2):140-52. PubMed ID: 15910240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis.
    Gupta P; Gurudutta GU; Saluja D; Tripathi RP
    J Cell Mol Med; 2009; 13(11-12):4349-63. PubMed ID: 19382896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells.
    Sarrazin S; Mossadegh-Keller N; Fukao T; Aziz A; Mourcin F; Vanhille L; Kelly Modis L; Kastner P; Chan S; Duprez E; Otto C; Sieweke MH
    Cell; 2009 Jul; 138(2):300-13. PubMed ID: 19632180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.